Literature DB >> 6449563

Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects.

E G Spokes, N J Garrett, M N Rossor, L L Iversen.   

Abstract

Gamma-aminobutyric acid (GABA) concentrations were measured in 10 regions of post-mortem brain from control, psychotic and choreic subjects; glutamate decarboxylase (GAD) activities were estimated in substantia nigra. In agreement with earlier observations, agonal status profoundly affected GAD measurements in the substantia nigra but had no effect on GABA levels in any brain region. Although GAD and GABA levels were significantly correlated in nigral tissue from sudden death control and psychotic cases, the association was lost in patients dying slowly. In Huntington's chorea significant reduction in GABA content were observed in the nucleus accumbens, lateral pallidum, subthalamic nucleus, substantia nigra and ventrolateral thalamic nucleus. In psychotic patients there were significant decreases in GABA concentrations in the amygdala and nucleus accumbens. Division of the psychotic group into schizophrenia and schizophrenia-like categories and into early-onset and later-onset cases revealed that GABA levels in the amygdala were diminished in all 4 psychotic subgroups, whereas in the nucleus accumbens the deficit was confined to cases of early-onset schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6449563     DOI: 10.1016/0022-510x(80)90103-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  25 in total

1.  Amygdala abnormalities in first-degree relatives of individuals with schizophrenia unmasked by benzodiazepine challenge.

Authors:  Daniel H Wolf; Theodore D Satterthwaite; James Loughead; Amy Pinkham; Eve Overton; Mark A Elliott; Gersham W Dent; Mark A Smith; Ruben C Gur; Raquel E Gur
Journal:  Psychopharmacology (Berl)       Date:  2011-05-21       Impact factor: 4.530

Review 2.  Transcriptional regulation of GAD1 GABA synthesis gene in the prefrontal cortex of subjects with schizophrenia.

Authors:  Amanda C Mitchell; Yan Jiang; Cyril Peter; Schahram Akbarian
Journal:  Schizophr Res       Date:  2014-10-31       Impact factor: 4.939

3.  EGF Treatment Improves Motor Behavior and Cortical GABAergic Function in the R6/2 Mouse Model of Huntington's Disease.

Authors:  Felecia M Marottoli; Mercedes Priego; Eden Flores-Barrera; Rohan Pisharody; Steve Zaldua; Kelly D Fan; Giri K Ekkurthi; Scott T Brady; Gerardo A Morfini; Kuei Y Tseng; Leon M Tai
Journal:  Mol Neurobiol       Date:  2019-05-19       Impact factor: 5.590

Review 4.  Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.

Authors:  Joseph T Coyle; Alo Basu; Michael Benneyworth; Darrick Balu; Glenn Konopaske
Journal:  Handb Exp Pharmacol       Date:  2012

5.  Protein Markers of Neurotransmitter Synthesis and Release in Postmortem Schizophrenia Substantia Nigra.

Authors:  Kirsten E Schoonover; Lesley A McCollum; Rosalinda C Roberts
Journal:  Neuropsychopharmacology       Date:  2016-08-23       Impact factor: 7.853

Review 6.  Pharmacodynamic effects and possible therapeutic uses of THIP, a specific GABA-agonist.

Authors:  A V Christensen; O Svendsen; P Krogsgaard-Larsen
Journal:  Pharm Weekbl Sci       Date:  1982-10-22

Review 7.  The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?

Authors:  Junghee Lee; Jung Hyun Boo; Hoon Ryu
Journal:  Adv Drug Deliv Rev       Date:  2009-08-27       Impact factor: 15.470

8.  GABA and homovanillic acid in the plasma of Schizophrenic and bipolar I patients.

Authors:  Aurora Arrúe; Ricardo Dávila; Mercedes Zumárraga; Nieves Basterreche; Miguel A González-Torres; Biotza Goienetxea; Maria I Zamalloa; Juan B Anguiano; José Guimón
Journal:  Neurochem Res       Date:  2009-08-22       Impact factor: 3.996

Review 9.  Structural plasticity of interneurons in the adult brain: role of PSA-NCAM and implications for psychiatric disorders.

Authors:  Juan Nacher; Ramon Guirado; Esther Castillo-Gómez
Journal:  Neurochem Res       Date:  2013-01-26       Impact factor: 3.996

10.  Gamma-aminobutyrate aminotransferase activity in brains of schizophrenic patients.

Authors:  F Sherif; L Eriksson; L Oreland
Journal:  J Neural Transm Gen Sect       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.